To include your compound in the COVID-19 Resource Center, submit it here.

ODAC votes against Maxamine

An FDA advisory panel on Wednesday concluded that Maxim Pharmaceuticals (MAXM; SSE:MAXM) failed to demonstrate the efficacy or safety of Maxamine histamine hydrochloride combined

Read the full 247 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE